Skip to main content

Advertisement

SpringerLink
Log in

No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

The genetic polymorphism of p53 codon 72 Arg/Pro has been implicated in oral cancer risk, but the results of previous studies remain controversial and ambiguous. To estimate the effect of the p53 codon 72 Arg/Pro polymorphism on the risk of oral cancer, a meta-analysis was performed. Based on a comprehensive search in PubMed, Embase, Web of Science, and China National Knowledge Infrastructure (CNKI) databases, we identified all available publications assessing the association between p53 codon 72 Arg/Pro polymorphism and oral cancer risk. The pooled odds ratio (OR) with its corresponding 95 % confidence interval (CI) was calculated to assess the association. Subgroup analyses by ethnicity and study quality were performed to further identify the correlation. Totally, 17 studies with 2,975 cases and 3,413 controls were included into this meta-analysis. There was no statistically significant association between the p53 codon 72 Arg/Pro polymorphism and oral cancer risk in all genetic contrast models (ORPro allele vs. Arg allele = 1.05, 95 % CI 0.94–1.18, POR = 0.379; ORPro/Pro vs. Arg/Arg = 1.11, 95 % CI 0.89–1.40, POR = 0.356; ORPro/Arg vs. Arg/Arg = 1.10, 95 % CI 0.93–1.30, POR = 0.256; ORPro/Arg + Pro/Pro vs. Arg/Arg = 1.10, 95 % CI 0.93–1.31, POR = 0.263; and ORPro/Pro vs. Arg/Arg + Pro/Arg = 1.03, 95 % CI 0.90–1.18, POR = 0.647). In the subgroup analysis of high-quality studies, we failed to find the susceptibility of p53 codon 72 Arg/Pro polymorphism to oral cancer. Moreover, the results were similar among Asians, Caucasians, and mixed populations when stratifying by ethnicity. Sensitivity analysis further confirmed the stability of the results. The present meta-analysis of currently available data shows no association between the p53 codon 72 Arg/Pro polymorphism and oral cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tanaka T, Tanaka M. Oral carcinogenesis and oral cancer chemoprevention: a review. Patholog Res Int. 2011;2011:431246.

    PubMed  Google Scholar 

  2. Petersen PE. Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol. 2009;45:454–60.

    Article  PubMed  Google Scholar 

  3. Wang Z, Sturgis EM, Zhang Y, Huang Z, Zhou Q, Wei Q, et al. Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer. 2012;131:E251–8.

    Article  PubMed  CAS  Google Scholar 

  4. Chen X, Sturgis EM, Lei D, Dahlstrom K, Wei Q, Li G. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res. 2010;70:7199–208.

    Article  PubMed  CAS  Google Scholar 

  5. Anantharaman D, Samant TA, Sen S, Mahimkar MB. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol. 2011;47:866–72.

    Article  PubMed  CAS  Google Scholar 

  6. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991;253:49–53.

    Article  PubMed  CAS  Google Scholar 

  7. Suzuki K, Matsubara H. Recent advances in p53 research and cancer treatment. J Biomed Biotechnol. 2011;2011:978312.

    PubMed  Google Scholar 

  8. Sjalander A, Birgander R, Kivela A, Beckman G. p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered. 1995;45:144–9.

    Article  PubMed  CAS  Google Scholar 

  9. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett. 2004;210:151–7.

    Article  PubMed  CAS  Google Scholar 

  10. Wang YC, Chen CY, Chen SK, Chang YY, Lin P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res. 1999;5:129–34.

    PubMed  CAS  Google Scholar 

  11. Zehbe I, Voglino G, Wilander E, Delius H, Marongiu A, Edler L, et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 2001;61:608–11.

    PubMed  CAS  Google Scholar 

  12. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393:229–34.

    Article  PubMed  CAS  Google Scholar 

  13. Mabrouk I, Baccouche S, El-Abed R, Mokdad-Gargouri R, Mosbah A, Said S, et al. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci. 2003;1010:764–70.

    Article  PubMed  CAS  Google Scholar 

  14. Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005;13:840–8.

    Article  PubMed  CAS  Google Scholar 

  15. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.

    PubMed  CAS  Google Scholar 

  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  Google Scholar 

  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  19. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559–73.

    Article  PubMed  Google Scholar 

  20. Tobias, A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8:15–7.

    Google Scholar 

  21. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70–1.

    Article  PubMed  CAS  Google Scholar 

  22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed  CAS  Google Scholar 

  23. Jing G, Lv K, Jiao X. The p53 codon 72 polymorphism and the risk of oral cancer in a Chinese Han population. Genet Test Mol Biomarkers. 2012;16:1149–52.

    Article  PubMed  CAS  Google Scholar 

  24. Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, et al. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India. DNA Cell Biol. 2011;30:163–71.

    Article  PubMed  CAS  Google Scholar 

  25. Saini R, Tang TH, Zain RB, Cheong SC, Musa KI, Saini D, et al. Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol. 2011;137:311–20.

    Article  PubMed  CAS  Google Scholar 

  26. Misra C, Majumder M, Bajaj S, Ghosh S, Roy B, Roychoudhury S. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinog. 2009;48:790–800.

    Article  PubMed  CAS  Google Scholar 

  27. Chen X, Sturgis EM, El-Naggar AK, Wei Q, Li G. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis. 2008;29:2120–5.

    Article  PubMed  CAS  Google Scholar 

  28. Tu HF, Chen HW, Kao SY, Lin SC, Liu CJ, Chang KW. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol. 2008;87:243–52.

    Article  PubMed  CAS  Google Scholar 

  29. Lin YC, Huang HI, Wang LH, Tsai CC, Lung O, Dai CY, et al. Polymorphisms of COX-2–765 G > C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Oral Oncol. 2008;44:798–804.

    Article  PubMed  CAS  Google Scholar 

  30. Bau DT, Tsai MH, Lo YL, Hsu CM, Tsai Y, Lee CC, et al. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer Res. 2007;27:1559–64.

    PubMed  CAS  Google Scholar 

  31. Kuroda Y, Nakao H, Ikemura K, Katoh T. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol. 2007;43:1043–8.

    Article  PubMed  CAS  Google Scholar 

  32. Hsieh LL, Huang TH, Chen IH, Liao CT, Wang HM, Lai CH, et al. p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan. Br J Cancer. 2005;92:30–5.

    Article  PubMed  CAS  Google Scholar 

  33. Kietthubthew S, Sriplung H, Au WW, Ishida T. The p53 codon 72 polymorphism and risk of oral cancer in Southern Thailand. Asian Pac J Cancer Prev. 2003;4:209–14.

    PubMed  Google Scholar 

  34. Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, et al. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem. 2003;252:117–24.

    Article  PubMed  CAS  Google Scholar 

  35. Drummond SN, De Marco L. Pordeus Ide A, Barbosa AA, Gomez RS. TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res. 2002;22:3379–81.

    PubMed  CAS  Google Scholar 

  36. Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer. 2002;97:649–53.

    Article  PubMed  CAS  Google Scholar 

  37. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case–control study. Cancer Lett. 2002;183:123–30.

    Article  PubMed  CAS  Google Scholar 

  38. Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer. 2001;84:739–42.

    Article  PubMed  CAS  Google Scholar 

  39. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:334–9.

    Article  PubMed  CAS  Google Scholar 

  40. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–10.

    Article  PubMed  CAS  Google Scholar 

  41. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev. 2004;13:11–22.

    Article  PubMed  CAS  Google Scholar 

  42. Zhuo XL, Cai L, Xiang ZL, Zhuo WL, Wang Y, Zhang XY. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis. Arch Med Res. 2009;40:299–305.

    Article  PubMed  CAS  Google Scholar 

  43. Zhuo XL, Li Q, Zhou Y, Cai L, Xiang ZL, Yuan W, et al. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility. Arch Med Res. 2009;40:625–34.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Orthodontics, School of Stomatology, The Fourth Military Medical University, No. 145 West Changle Road, Xi’an, 710032, Shaanxi Province, People’s Republic of China

    Ning Jiang, Lei Wang & Yin-Zhong Duan

  2. Department of Orthodontics, Shanghai Stomatological Disease Center, Shanghai, 200031, People’s Republic of China

    Jie Pan

Authors
  1. Ning Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yin-Zhong Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yin-Zhong Duan.

Additional information

N. Jiang and J. Pan contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, N., Pan, J., Wang, L. et al. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer. Tumor Biol. 34, 587–596 (2013). https://doi.org/10.1007/s13277-012-0587-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-012-0587-9

Keywords

Search

Navigation